SAN MATEO, Calif.–(BUSINESS WIRE)–Dec 23, 2024–. BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends …
SAN MATEO, Calif.–(BUSINESS WIRE)–Dec 23, 2024–. BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends …
In